Bipartisan Bill Aims to Cap Insulin Costs for Private Insurance Holders

A new bipartisan bill has been introduced to cap the monthly cost of insulin at $35 for Americans with private insurance. The legislation also proposes establishing a pilot program to increase affordability for uninsured individuals in ten states.

Legislative Details and Background

The bill was introduced last week by Senators Jeanne Shaheen (D-Maine), Raphael Warnock (D-Ga.), Susan Collins (R-Maine), and John Kennedy (R-La.). It builds upon previous efforts, including the 2022 Inflation Reduction Act, which lowered insulin costs for Medicare beneficiaries.

Similar attempts to cap insulin costs have faced hurdles in the past. A $35 cap for private insurance passed by the House in 2022 failed to pass the Senate, and a similar inclusion in the Inflation Reduction Act was ultimately opposed by Republicans.

The Need for Affordable Insulin

Approximately 8.1 million Americans use insulin, according to the U.S. Centers for Disease Control and Prevention. Over 2 million of these individuals have Type 1 diabetes and require regular insulin access to survive. Insulin is also crucial for managing glucose levels in other forms of diabetes.

Despite some state-level co-pay caps ranging from $25 to $100, many Americans remain vulnerable to high costs. Approximately 57% of individuals with private insurance have self-insured plans that are not subject to state regulations, leaving them without cost protections.

Industry and Advocate Responses

Dr. Leslie Eiland, an adult endocrinologist at the University of Nebraska Medical Center, emphasized the burden placed on patients to navigate cost savings programs. Pharmaceutical companies like Sanofi and Novo Nordisk have highlighted their existing savings programs and commitment to affordability.

Chanse Jones, a spokesperson for PhRMA, the pharmaceutical trade association, pointed to pharmacy benefit managers and insurers as potential barriers to access, even as manufacturers work to expand access.

Personal Impact and Future Outlook

Breana Glover, a 23-year-old restaurant server in Houston, shared her experience of limiting carbohydrate intake to stretch her insulin supply. She believes a $35 cap would significantly improve accessibility to essential healthcare and other necessities.

Manny Hernandez, CEO of The Diabetes Link, expressed optimism following meetings with Republican lawmakers but acknowledged the potential for competing priorities to derail the bill. Advocates remain hopeful, despite past setbacks.